Sanofi Sa · EURONEXT:SAN
Sanofi Sa — Sanofi India — Q3 2023 Earnings Presentation
10 slides from Sanofi Sa's earnings presentation, Nov 15, 2023
Slide 1: Outcome of Investor / Analysts Call letter to stock exchanges
15th November 2023 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor Dalal Street, Mumbai - 400 001 Plot No. C/1, G Block Scrip Code: 500674 Bandra-Kurla Complex, Bandra East Mumbai - 400 050 Symbol: SANOFI Sub: O
Slide 2: Investor Presentation
Investor Presentation November 15, 2023
Slide 3: Disclaimer
Disclaimer This Release / Communication, except for the historical information, may contain statements, including the words or phrases such as expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should and similar expressions or
Slide 4: SIL India For India | Growth pillars
Internal SIL India For India | Growth pillars Go To Market / Diabetes CHC E2E Innovation Operating Efficiencies • Double down on • Strengthen • Leverage global and • Customer centric & winning brand hybrid models positioning local innovation Allegra • Trade Organization, • Expand spectrum • Deepen c
Slide 5: New Product Launches are on Track
Internal New Product Launches are on Track Oct 23 Dec 23 2024 2025 INTERNAL USE 3
Slide 6: India for India Strategy Yields Results
India for India Strategy Yields Results Internal SIL India For India | Growth pillars GTM/Operating Diabetes CHC E2E Innovation Efficiencies • Double down on • Strengthen • Leverage global and • Customer centric & winning brand hybrid models positioning local innovation Allegra • Trade Organization,
Slide 7: Consistent Increase in Operating Profit
Internal Consistent Increase in Operating Profit Operating Profit Operating Profit (Absolute value) (in Percentage) 2500 35% 32.50% 2244 31.10% 2057 30% 28% 26.40% 27.40% 2000 1856 1736 1774 25% 23.80% 1543 1500 20% 1000 15% 10% 500 5% 0 0% Q1 Q2 Q3 Q1 Q2 Q3 2022 2023 2022 2023 In million INR 5
Slide 8: Global standalone organization of the consumer healthcare business
In the rest of the world as well as in India, implementing the global standalone organization of the consumer healthcare (CHC) business is the best platform to unleash its growth potential
Slide 9: Demerger Status Update
May 10, 2023 Board approval Filing with Stock Exchange and SEBI The elements and propositions included in this document are only work hypotheses. Any Decision which might impact current End of August Demerger Early October Filing with NCLT Status organization structure will be taken according to leg
Slide 10: Thank you
Thank you sonofi